Is autism curable?

Developmental Medicine and Child Neurology

Volumn 56, Issue 10, 2014, Pages 927-931

  Bölte, Sven ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTISM; COPY NUMBER VARIATION; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EXTERNAL VALIDITY; FUNCTIONAL DISEASE; GENETIC DISORDER; GOLD STANDARD; HUMAN; NERVE CELL DIFFERENTIATION; NONHUMAN; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW (TOPIC); CHILD DEVELOPMENT DISORDERS, PERVASIVE; CONVALESCENCE; GENETICS; PHYSIOLOGY;

CHILD DEVELOPMENT DISORDERS, PERVASIVE; HUMANS; RECOVERY OF FUNCTION;

EID: 84908482141     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12495     Document Type: Review

References (31)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edn (DSM-5). Arlington, VA: American Psychiatric Publishing, 2013.
2. Magiati I, Tay XW, Howlin P. Cognitive, language, social and behavioural outcomes in adults with autism spectrum disorders: a systematic review of longitudinal follow-up studies in adulthood. Clin Psychol Rev 2013; 34: 73-86.
3. Knapp M, Romeo R, Beecham J. Economic cost of autism in the UK. Autism 2009; 13: 317-36.
4. Lichtenstein P, Carlström E, Råstam M, Gillberg C, Anckarsäter H. The genetics of autism spectrum disorder and related neuropsychiatric disorders in childhood. Am J Psychiatry 2010; 167: 1357-63.
5. Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev 2010; 22: 229-37.
6. Grafodatskaya D, Chung B, Szatmari P, Weksberg R. Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry 2010; 49: 794-809.
7. Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: a decade of new twin studies. Am J Med Genet B Neuropsychiatr Genet 2011; 156: 255-74.
8. Hertz-Picciotto I. Can autism spectrum conditions be caused by environmental factors. In: Bölte S, Hallmayer J, editors. Autism Spectrum Conditions. Göttingen: Hogrefe, 2010: 100-1.
9. Vissers ME, Cohen MX, Geurt HM. Brain connectivity and high functioning autism: a promising path of research that needs refined models methodological convergence and stronger behavioral links. Neurosci Biobehav Rev 2012; 36: 604-25.
10. Geschwind DH, Lewitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 2007; 17: 103-11.
11. Howlin P. How can outcome be measured in ASC? In: Bölte S, Hallmayer J, editors. Autism Spectrum Conditions. Göttingen: Hogrefe, 2010: 146-9.
12. Kaplan G, McCracken JT. Psychopharmacology of autism spectrum disorders. Pediatr Clin North Am 2012; 59: 175-87.
13. Reichow B, Barton EE, Boyd BA, Hume K. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Syst Rev 2012; 10: CD009260.
14. Reichow B, Steiner AM, Volkmar F. Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD). Cochrane Database Syst Rev 2012; 11: 7.
15. Oono IP, Honey EJ, McConachie H. Parent-mediated early intervention for young children with autism spectrum disorders (ASD). Cochrane Database Syst Rev 2013; 30: 4.
16. Helt M, Kelley E, Kinsbourne M, et al. Can children with autism recover? If so, how? Neuropsychol Rev 2008; 18: 339-66.
17. Fein D, Barton M, Eigsti IM, et al. Optimal outcome in individuals with a history of autism. J Child Psychol Psychiatry 2013; 54: 195-205.
18. Lovaas OI. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol 1987; 55: 3-9.
19. Granpeesheh D, Tarbox J, Dixon DR, Carr E, Herbert M. Retrospective analysis of clinical records in 38 cases of recovery from autism. Ann Clin Psychiatry 2009; 21: 195-204.
20. Silverman JL, Crawley JN. The promising trajectory of autism therapeutics discovery. Drug Discov Today 2014; 19: 838-44.
21. Delorme R, Ey E, Toro R, Leboyer M, Gillberg C, Bourgeron T. Progress toward treatments for synaptic defects in autism. Nat Med 2013; 19: 685-94.
22. Williams SC. Drugs targeting mGluR5 receptor offer 'fragile' hope for autism. Nat Med 2012; 18: 840.
23. Ehninger D, Silva AJ. Rapamycin for treating tuberous sclerosis and autism spectrum disorders. Trends Mol Med 2011; 17: 78-87.
24. Christensen J, Grønborg TK, Sørensen MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013; 309: 1696-703.
25. Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science 2007; 316: 445-9.
26. Bölte S, de Schipper E, Robison JE, et al. Classification of functioning and impairment: the development of ICF core sets for autism spectrum disorder. Autism Res 2014; 7: 167-72.
27. Happé F, Frith U. The beautiful otherness of the autistic mind. Philos Trans R Soc Lond B Biol Sci 2009; 364: 1346-50.
28. Welterlin A, Turner-Brown LM, Harris S, Mesibov G, Delmolino L. The home TEACCHing program for toddlers with autism. J Autism Dev Disord 2012; 42: 1827-35.
29. Selfe L. Nadia: A Case of Extraordinary Drawing Ability in an Autistic Child. London: Academic Press, 1977.
30. Kapp SK, Gillespie-Lynch K, Sherman LE, Hutman T. Deficit, difference, or both? Autism and neurodiversity. Dev Psychol 2013; 49: 59-71.
31. Ecker C, Spooren W, Murphy D. Developing new pharmacotherapies for autism. J Intern Med 2013; 274: 308-20.